Tomocube, Inc. (KOSDAQ:475960)

South Korea · Delayed Price · Currency is KRW

36,750

-1,250 (-3.29%)

At close: Jul 16, 2026

45.26% (1Y)

Market Cap	485.81B +44.1%
Revenue (ttm)	13.40B +148.9%
Net Income	-3.38B
EPS	-254.79
Shares Out	13.38M
PE Ratio	n/a
Forward PE	133.95
Dividend	n/a
Ex-Dividend Date	n/a

Volume	56,467
Open	37,600
Previous Close	38,000
Day's Range	35,150 - 37,600
52-Week Range	22,500 - 67,800
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 13, 2026

About Tomocube

Tomocube, Inc. engages in the manufacture and sale of optical devices and medical equipment. Its holotomography (HT) products include HT-X1 for live-cell imaging and analysis; and HT-2H for 3D live cell imaging. The company also offers TomoAnalysis, a 3D image visualization and analysis software. In addition, it provides accessories, such as HT-ready 96 well plates; TomoDish that is designed to accommodate both adherent and suspension cells; TomoChamber, a stage-top incubator designed for long-term live cell imaging; TomoPlate, an active vibrat... [Read more]

Industry Laboratory Apparatus and Furniture

Founded 2015

Country South Korea

Stock Exchange KOSDAQ

Ticker Symbol 475960

Full Company Profile

Financial Performance

In 2025, Tomocube's revenue was 11.31 billion, an increase of 90.39% compared to the previous year's 5.94 billion. Losses were -4.81 billion, -42.06% less than in 2024.

Financial Statements